国际妇产科学杂志2024,Vol.51Issue(3) :306-311.DOI:10.12280/gjfckx.20231063

妊娠恶心呕吐的妊娠期管理现状与展望

Current Situation and Prospect of Pregnancy Management of Nausea and Vomiting in Pregnancy

马丽娜 漆海宁 邢建红 刘梅 宋沁雯 刘洋 秦莹 吴效科
国际妇产科学杂志2024,Vol.51Issue(3) :306-311.DOI:10.12280/gjfckx.20231063

妊娠恶心呕吐的妊娠期管理现状与展望

Current Situation and Prospect of Pregnancy Management of Nausea and Vomiting in Pregnancy

马丽娜 1漆海宁 2邢建红 2刘梅 2宋沁雯 3刘洋 4秦莹 2吴效科4
扫码查看

作者信息

  • 1. 250014 济南,山东中医药大学附属医院;山东中医药大学博士后流动站
  • 2. 250014 济南,山东中医药大学附属医院
  • 3. 山东中医药大学第一临床医学院
  • 4. 黑龙江中医药大学附属第一医院
  • 折叠

摘要

妊娠恶心呕吐(nausea and vomiting of pregnancy,NVP)是妊娠期最常见的症状之一,严重、持续的NVP会进展为妊娠剧吐(hyperemesis gravidarum,HG),对母胎均有不同程度的影响,严重者可导致终止妊娠.目前NVP的发病机制尚不清楚,但普遍认为其与遗传、内分泌和感染等因素密切相关.故临床上对NVP的妊娠期管理主要以对症治疗、防治严重的并发症为主,同时尽量减少对母胎的不良影响,主要包括非药物治疗、止吐药物治疗及常规补液治疗等.非药物治疗包括调整生活方式和饮食习惯,以及建议孕妇在妊娠前3个月禁止服用含铁补充剂或含铁维生素.常用止吐药物包括维生素B6或联合多西拉敏、甲氧氯普胺、昂丹司琼、异丙嗪和糖皮质激素等.

Abstract

Nausea and vomiting of pregnancy(NVP)is one of the most common symptoms of pregnancy,severe and persistent NVP can progress to hyperemesis gravidarum(HG),affecting both the mother and fetus to varying degrees.Severe cases lead to the termination of pregnancy.At present,the pathogenesis of NVP is not clear,but it is generally believed that it is closely related to genetic,endocrine and infection factors.Therefore,the current clinical management of NVP during pregnancy mainly focuses on symptomatic treatment,prevention and treatment of serious complications,while minimizing adverse effects on the mother and fetus,including non-drug treatment,antiemetic drug treatment and routine rehydration treatment.Non-pharmacological treatments include adjustments to lifestyle and diet,as well as advising women not to take iron supplements or iron-containing vitamins during the first three months of pregnancy.Common antiemesis drugs include vitamin B6 or combined doxylamine,metoclopramide,ondansetron,promethazine,glucocorticoids,etc.

关键词

妊娠恶心呕吐/妊娠剧吐/妊娠期管理/病因/治疗

Key words

Nausea and vomiting of pregnancy/Hyperemesis gravidarum/Pregnancy management/Etiological Factors/Therapy

引用本文复制引用

基金项目

国家重大疑难疾病中西医临床协作试点项目(国中医药办医政发[2018]3号)

出版年

2024
国际妇产科学杂志
天津市医学科学技术信息研究所

国际妇产科学杂志

CSTPCD
影响因子:1.155
ISSN:1674-1870
段落导航相关论文